Mapping The Nutraceuticals World

Nutraceuticals World

This podcast focuses on the B2B nutritional products marketplace, delivering analysis and insight on trends, challenges, and opportunities.

  1. Nov 3

    Active Nutrition: Bridging the Gap Between Joint Health and Muscle Recovery

    Violetta Insolia discusses evolving consumer needs, the science behind Bionap’s VERBALIEF™, an extract from Great Mullein leaves, and opportunities for integrated joint and muscle support.   Active nutrition is expanding beyond sports performance as consumers prioritize everyday wellness, mobility, muscle health, and healthy aging. In this podcast, Violetta Insolia, Business Development & Marketing Manager at Bionap, discusses top category trends, including growing interest among active older adults and GLP-1 medication users, as well as expectations for clinically supported ingredients.   Bionap recently introduced VERBALIEF™, a standardized extract from Great Mullein leaves, to support joint health and muscle function together. Insolia discussed the ingredient’s proposed mechanisms of action, findings from a randomized, double-blind, placebo-controlled clinical trial in active adults, opportunities for product formulation, and more.    Topics Covered   ·      Growth drivers in the active nutrition market ·      Emerging opportunities to support muscle health among GLP-1 users ·      Demand for scientific evidence and clinically substantiated ingredients ·      VERBALIEF™ Great Mullein extract: standardization, proposed mechanisms of action, and daily dosage ·      Clinical research evaluating joint comfort, muscle recovery, soreness, stiffness, and performance-related measures in active adults ·      Formulation opportunities  ·      Botanical sourcing, vertically integrated production, and sustainability initiatives

  2. Oct 7

    The Modern Standard for Saffron: Why Traceability and Clinical Evidence Matter

    As consumer interest in holistic wellness continues to grow, mood, stress, and sleep are increasingly viewed as interconnected health priorities. In this podcast, Ava Ghobadpour MS, RD, business development manager, U.S./Canada, Pharmactive, discusses the evolving saffron market and the science behind the company's proprietary Affron saffron extract, which is distributed by Saanroo in the U.S.  Ghobadpour explains why clinically validated botanical ingredients are gaining traction as consumers seek gentle, everyday solutions that support emotional well-being.  Affron stands out from conventional saffron extracts due to its standardized bioactive compounds, clinically studied dosing, and portfolio of 13 human clinical trials spanning adolescents to menopausal women. The conversation also explores the importance of quality assurance in the saffron supply chain. Because saffron is among the world's most valuable botanicals, adulteration remains a significant concern.  Ghobadpour outlines Pharmactive's sourcing practices, proprietary extraction process, DNA testing, and full traceability system designed to ensure ingredient authenticity and consistency. Topics discussed: Consumer demand for integrated mood, stress, and sleep supportThe clinical research behind Affron saffron extractStandardization, dosing, and formulation versatilityHuman clinical studies across multiple populationsSaffron supply chain challenges and adulteration risksDNA testing, traceability, and quality assuranceThe role of clinically validated botanicals in product innovation

  3. Mar 25

    Immune Resilience and Personalized Nutrition: Jeffrey Bland on Healthy Aging Today and Tomorrow

    At the 45th Natural Products Expo West, Jeffrey Bland, PhD, founder of Big Bold Health and a pioneer in functional medicine, reflected on more than four decades of progress in the natural products industry and where it’s headed next. A trained nutritional biochemist, Bland has long advocated for elevating the role of nutrition science in standard medical practice. He believes the industry is entering a pivotal phase defined by clinical validation, measurable outcomes, and personalized health strategies. Over his 30-year career, Bland has contributed to hundreds of clinical studies and helped develop numerous products grounded in measurable outcomes. Key to this process, he noted, is identifying meaningful biomarkers that can demonstrate how nutritional interventions impact the body. That scientific focus will culminate in an 850-person, double-blind, placebo-controlled trial investigating the effects of Tartary buckwheat sprouts on immune aging and longevity, Bland said. Expected to conclude in mid-2026, the study aims to provide robust human data on how targeted nutrition can influence immune resilience, an area Bland believes is central to reducing chronic disease risk and supporting healthy aging. Looking ahead, Bland believes the industry must move beyond unsupported claims toward demonstrable clinical value. For Big Bold Health, that means continuing to invest in rigorous research and applying those findings to both product development and consumer education. Subscribe to our weekly newsletter to stay current with all our content.

  4. Mar 18

    Creatine, Active Nutrition Help Fuel Dietary Supplement Market Growth

    At Natural Products Expo West 2026, Scott Dicker, senior director of market insights at SPINS, discussed dietary supplement industry trends, highlighting strong growth in both brick-and-mortar and e-commerce, with the natural products channel posting the strongest in-store growth. At the same time, Amazon remains the fastest-growing channel overall. Unit sales in natural retail are rising even faster than dollar sales in many categories, a positive signal for long-term category health. Active and Performance Nutrition The active nutrition segment has now led supplement category growth for five consecutive years, Dicker noted, with protein products appealing to a broad range of consumers. Creatine stands out as one of the category’s most notable success stories, and Dicker expects momentum to continue. Historically associated with male gym-goers seeking muscle gains, creatine is now reaching a broader audience, including women. New delivery formats such as gummies and beverages are emerging, and additional indications like cognitive health are offering new directions for brands. As competition intensifies within the creatine market, brands are exploring new ways to differentiate. Dicker pointed to premium positioning strategies, including sourcing claims and certification labels, as well as formulation innovations. Common ingredient pairings, such as creatine with protein, collagen, colostrum, or HMB, are becoming more common, while alternative forms could re-emerge as companies look for new ways to stand out in a crowded marketplace. Beyond creatine, Dicker highlighted several important trends in performance nutrition. Hydration supplements continue to grow rapidly, even as traditional ready-to-drink sports beverages flatten. The category offers a tale of two nutrients, he noted. Low- and no-sugar formulations remain on trend, along with high-sodium recovery products, which reflects a shift in perception from a once-vilified ingredient to a functional nutrient. Energy and pre-workout products are also evolving. Brands are experimenting with different caffeine levels and stimulant strategies to target specific usage occasions throughout the day. Some products are reducing caffeine levels to create more moderate options, while others are exploring alternatives such as paraxanthine. At the same time, brands are layering additional functional ingredients, such as nootropics or protein, to differentiate formulations. Hormone Health Looking ahead, Dicker said one of the biggest emerging themes for the supplement industry will be testosterone and hormone-related health. The growing use of GLP-1 medications and other medical wellness treatments has increased consumer comfort with pharmaceutical interventions and medicalized wellness approaches. As a result, interest in hormone optimization, including testosterone therapy, is rising. This shift could create opportunities for both companion products designed to support people using hormone therapies and natural alternatives aimed at supporting healthy testosterone levels. Nutrients such as zinc, magnesium, vitamin D, and boron may see renewed attention as consumers explore different ways to manage hormone health. Overall, Dicker suggested the supplement market remains dynamic, with strong growth fueled by evolving consumer demographics, new functional benefits, and ongoing innovation in ingredients and delivery formats.

  5. 03/22/2024

    NAD+ and Aging: ChromaDex CEO Rob Fried Discusses Science, Industry Challenges and Future Expectations

    With rising interest in healthy aging, more people are looking for clinical research that supports products designed to help them live healthier for longer. The coenzyme NAD+ is essential to the body's metabolic processes, but it declines with age, so supplements that boost NAD+ have garnered considerable attention in the scientific community. ChromaDex, which is publicly traded on the Nasdaq, offers the consumer product brand Tru Niagen. This patented form of nicotinamide riboside (NR) is a precursor to NAD+. Tru Niagen sales totaled nearly $70 million last year, accounting for the majority of the company’s $83.6 million in revenue. In this interview, ChromaDex CEO Rob Fried discusses NAD+ and emerging research, the company’s evolution to become a consumer-focused nutraceutical, the future of aging, critical challenges in today’s dietary supplement market, and more. Spoiler alert: Fried is calling for more accountability and collaboration to enforce quality standards and establish greater trust with consumers. In addition to being CEO of ChromaDex since 2017 and the founder of Tru Niagen, Fried is an Academy Award and Emmy Award winning motion picture producer. Before his combined 7 years in the health industry, he held senior roles at entertainment companies Savoy Pictures (CEO), Columbia Pictures (Executive Vice President) and Fried Films (founder, CEO). He has also founded and served as CEO of internet companies Feeln (now Hallmark Movies Now), WHN (a leading e-commerce service provider), and Healthspan Research LLC.  In 2017, Fried led ChromaDex’s acquisition of Healthspan Research LLC, a consumer company offering Tru Niagen products, and raised funds with Horizon Ventures to offer Tru Niagen direct-to-consumer. He holds a BS from Cornell University and an MBA from the Columbia University Graduate School of Business.

About

This podcast focuses on the B2B nutritional products marketplace, delivering analysis and insight on trends, challenges, and opportunities.